Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Agilent Technologies� filings rarely read like a simple story—they combine life-science breakthroughs, diagnostic regulations, and consumables economics in hundreds of pages. If you have ever tried to trace chromatography margins across segments or confirm executive stock sales before a product launch, you know the challenge.
Stock Titan’s AI-powered analysis turns that complexity into clarity. Whether you need the Agilent Technologies quarterly earnings report 10-Q filing to gauge consumables growth or an Agilent Technologies proxy statement executive compensation breakdown to benchmark R&D incentives, our platform delivers concise, plain-English takeaways the moment the document hits EDGAR. AGÕæÈ˹ٷ½-time alerts surface Agilent Technologies Form 4 insider transactions so you can monitor management moves without scrolling through PDF tables. Material developments? Our AI tags each Agilent Technologies 8-K material events explained note and links it to prior guidance.
Here’s how professionals use this page:
- Track Agilent Technologies insider trading Form 4 transactions and spot buying or selling trends by lab-equipment executives.
- Compare segment revenue, backlog, and China exposure across successive Agilent Technologies annual report 10-K simplified summaries.
- Dive into cash-flow forecasts with our AI annotations inside every Agilent Technologies earnings report filing analysis.
Stop parsing technical jargon line by line. With Stock Titan you’re understanding Agilent Technologies SEC documents with AI—from real-time Agilent Technologies Form 4 insider transactions to deep-dive 10-K footnotes—in minutes, not days.
Agilent Technologies reported the resignation of Robert W. McMahon from his role as Senior Vice President and Chief Financial Officer and named Rodney Gonsalves as interim Chief Financial Officer and interim Principal Financial Officer.
The Compensation Committee approved a bi-weekly salary stipend of $8,654 effective July 31, 2025 while Mr. Gonsalves serves as interim CFO and a grant of restricted stock units in a target amount of $1,000,000, subject to Agilent's standard equity award terms under its 2018 Stock Plan.
Agilent Technologies (NYSE: A) filed an 8-K disclosing that Chief Financial Officer Robert W. McMahon will resign effective 31 July 2025. The company states the departure is not linked to any disagreement over accounting, financial statements, internal controls, or operations.
The board has appointed Rodney Gonsalves—currently Vice President, Corporate Controller and Principal Accounting Officer—as interim CFO and Principal Financial Officer, also effective 31 July 2025. Gonsalves will retain his existing positions, and the filing notes no related-party transactions requiring disclosure under Regulation S-K Item 404(a).
A press release announcing the leadership change was issued on 15 July 2025 and furnished as Exhibit 99.1. Apart from the management transition, the filing contains no financial updates, guidance revisions, or strategic transactions.
Insider Trading Alert: Agilent Technologies (NYSE: A) Director Judy L. Brown reported a sale of 7.76 shares of Common Stock on June 18, 2025, at a price of $116.533 per share. Following the transaction, Brown retains direct ownership of 1,677 shares.
Key Transaction Details:
- Transaction was executed through a managed account where the reporting person lacks investment discretion
- Filing was submitted via attorney-in-fact Shirley Qin on June 23, 2025
- Transaction was reported as a direct ownership disposition (Form Code: S)
This relatively small insider sale represents a minor adjustment to the director's holdings and was executed through a managed account structure, suggesting it may be part of a broader portfolio management strategy rather than a significant directional bet on the company's prospects.